How relevant are the adverse effects of EGFR inhibitors used for small-cell lung cancer?
Abstract
EGFR inhibitors have notable adverse effects, including dermatologic and gastrointestinal issues, with substantial variability between agents. Direct data on their relevance to small-cell lung cancer is limited, indicating a need for further study.
Fields of Study & Subjects
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
HER2/EGFR in Cancer Research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 February 2026
- Language
- EN